Novavax, Inc. (FRA:NVV1)
Germany · Delayed Price · Currency is EUR 6.47
-0.07 (-1.07%)
Jan 8, 2026, 1:17 PM CET
Novavax Market Cap
Novavax has a market cap or net worth of €1.02 billion as of January 9, 2026. Its market cap has decreased by -23.70% in one year.
Market Cap
1.02B
Enterprise Value
575.67M
Revenue
907.40M
Ranking
n/a
PE Ratio
3.49
Stock Price
€6.47
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 27.26M to 1.02B, an increase of 3,625.63%. That is a compound annual growth rate of 13.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.02B | 9.20% |
| Dec 31, 2025 | 930.05M | -25.24% |
| Dec 31, 2024 | 1.24B | 141.15% |
| Dec 29, 2023 | 515.85M | -37.63% |
| Dec 30, 2022 | 827.03M | -91.31% |
| Dec 31, 2021 | 9.51B | 185.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 55.78B |
| Siemens Healthineers AG | 51.89B |
| Bayer Aktiengesellschaft | 38.20B |
| Fresenius SE & Co. KGaA | 27.73B |
| Sartorius Aktiengesellschaft | 15.77B |
| Fresenius Medical Care AG | 11.04B |
| Fielmann Group AG | 3.67B |
| Carl Zeiss Meditec AG | 3.61B |